Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer’s Disease
Journal of Alzheimer's Disease · 30.01.2024 · 97 (3) · 1139-1159
DOI: 10.3233/jad-230942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 30.01.2024. Verfasst von Makoto Kurano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Disturbed metabolism has been proposed as being involved in the pathogenesis of Alzheimer’s disease (AD), and more evidence from human AD brains is required.
Objective
In this study, we attempted to identify or confirm modulations in the levels of metabolites associated with AD in postmortem AD brains.
Methods
We performed metabolomics analyses using a gas chromatography mass spectrometry system in postmortem brains of patients with confirmed AD, patients with CERAD score B, and control subjects.
Results
Impaired phosphorylation of glucose and elevation of several tricarboxylic acid (TCA) metabolites, except citrate, were observed and the degree of impaired phosphorylation and elevation in the levels of the TCA cycle metabolites were negatively and positively correlated, respectively, with the clinical phenotypes of AD. The levels of uronic acid pathway metabolites were modulated in AD and correlated positively with the amyloid-β content. The associations of nucleic acid synthesis and amino acid metabolites with AD depended on the kinds of metabolites; in particular, the contents of ribose 5-phosphate, serine and glycine were negatively correlated, while those of ureidosuccinic acid and indole-3-acetic acid were positively modulated in AD. Comprehensive statistical analyses suggested that alterations in the inositol pathway were most closely associated with AD.
Conclusions
The present study revealed many novel associations between metabolites and AD, suggesting that some of these might serve as novel potential therapeutic targets for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
Zitieren
APA
Kurano, M., Saito, Y., & Yatomi, Y. (2024). Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer’s Disease. Journal of Alzheimer's Disease, 97(3), 1139-1159. https://doi.org/10.3233/jad-230942
Vancouver
Kurano M, Saito Y, Yatomi Y. Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024;97(3):1139-1159. doi:10.3233/jad-230942
BibTeX
@article{Kurano2024,
author = {Kurano, Makoto and Saito, Yuko and Yatomi, Yutaka},
title = {Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer’s Disease},
journal = {Journal of Alzheimer's Disease},
year = {2024},
volume = {97},
number = {3},
pages = {1139--1159},
doi = {10.3233/jad-230942}
}
EUVIMED